Inadequate therapeutic drug monitoring in patients with lithium toxicity in Japan

Psychiatry Clin Neurosci. 2020 Nov;74(11):629-631. doi: 10.1111/pcn.13147. Epub 2020 Sep 24.

Authors

Kouji Okada^{1

2}, Kazuo Yamada³, Kensuke Usui^{1

2}, Ryusuke Ouchi^{1

2}, Masashi Nibuya³, Ai Takahashi², Yuzo Shito², Yoshiteru Watanabe^{1

2}, Eiji Suzuki³

Affiliations

¹ Division of Clinical Pharmaceutics and Pharmacy Practice, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
² Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
³ Division of Psychiatry, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

PMID: 32909640
DOI: 10.1111/pcn.13147

No abstract available

Publication types

Letter

MeSH terms

Antimanic Agents / toxicity*
Bipolar Disorder / drug therapy*
Compensation and Redress*
Drug Monitoring / standards*
Drug-Related Side Effects and Adverse Reactions / economics*
Japan
Lithium Compounds / toxicity*

Substances

Antimanic Agents
Lithium Compounds